Dr. Stoller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave
3rd Floor
Pittsburgh, PA 15232Phone+1 412-235-1020Fax+1 412-235-1030
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 1971 - 1973
- Harvard Medical SchoolClass of 1971
Certifications & Licensure
- PA State Medical License 1978 - 2022
- WV State Medical License 1987 - 2003
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Clinical Trials
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma Start of enrollment: 2006 Oct 23
- ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors Start of enrollment: 2010 May 01
- Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma Start of enrollment: 2011 Jul 25
Publications & Presentations
PubMed
- 130 citationsRandomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastri...Manish A. Shah, Yelena Y. Janjigian, Ronald G. Stoller, Stephen Shibata, Margaret Kemeny
Journal of Clinical Oncology. 2015-11-20 - 1041 citationsReduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerJeffrey Crawford, Howard Ozer, Ronald G. Stoller, David H. Johnson, Gary H. Lyman
The New England Journal of Medicine. 1991-07-18 - 32 citationsFinal results of a placebo-controlled study of filgrastim in small-cell lung cancer: exploration of risk factors for febrile neutropenia.Jeffrey Crawford, John A. Glaspy, Ronald G. Stoller, Dianne Tomita, Martha Vincent
Supportive Cancer Therapy. 2005-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: